Literature DB >> 7944617

Immunohistochemical markers for arthritis in psoriasis.

D J Veale1, L Barnes, S Rogers, O FitzGerald.   

Abstract

OBJECTIVES: To examine the immunohistological features in the involved skin of patients with psoriatic arthritis (PA) (n = 15), compared with those in involved skin from patients with psoriasis but no arthritis (n = 5), and with a group with normal skin (n = 4), to identify markers for arthritis in psoriasis.
METHODS: Skin was obtained from patients by 6 mm punch biopsy and normal skin was provided by the department of plastic surgery. Samples were stained with monoclonal antibodies against T cells (CD3, CD8, CD4, CD45Ro), B cells (CD20), macrophages (mac387), vascular endothelium (FVIII-related antigen) and a Langerhan's cell marker (p155). The number of cells/vessels staining with each monoclonal antibody was calculated and serial sections of skin were examined to estimate the presence of DR+ keratinocytes.
RESULTS: There were significantly more CD45Ro T-cells and blood vessels in patients with psoriatic arthritis compared with both psoriasis alone, and with normal controls (p < 0.02). While B-cells were not seen in psoriasis without arthritis or in normal skin, a small but significant number were observed in PA (p < 0.02). Furthermore, while DR+ keratinocytes were present in both psoriatic arthritis and psoriasis skin, there were significantly more DR+ cells in the psoriatic arthritis epidermis compared with psoriasis alone (p < 0.02).
CONCLUSIONS: This study suggests that increased numbers of CD45Ro T-cells, greater vascularity, the presence of B-cells, and increased numbers of DR+ epidermal cells are markers for arthritis in patients with psoriasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944617      PMCID: PMC1005369          DOI: 10.1136/ard.53.7.450

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Investigation on Langerhans cells in pathological human epidermis.

Authors:  P Lisi
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

2.  Microcirculation in psoriatic skin.

Authors:  I M Braverman; A Yen
Journal:  J Invest Dermatol       Date:  1974-05       Impact factor: 8.551

3.  Association between rheumatoid arthritis and psoriasis in total populations.

Authors:  L Hellgren
Journal:  Acta Rheumatol Scand       Date:  1969

4.  The simultaneous presence of Langerhans' cell and interdigitating cell antigenic markers on inflammatory dendritic cells.

Authors:  V A Alegre; D M MacDonald; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

5.  Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.

Authors:  B S Baker; A F Swain; C E Griffiths; J N Leonard; L Fry; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

6.  Epidermal T lymphocytes and HLA-DR expression in psoriasis.

Authors:  B S Baker; A F Swain; L Fry; H Valdimarsson
Journal:  Br J Dermatol       Date:  1984-05       Impact factor: 9.302

Review 7.  Epidemiology in psoriasis research.

Authors:  E M Farber; L Nall
Journal:  Hawaii Med J       Date:  1982-11

8.  Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis.

Authors:  D Veale; G Yanni; S Rogers; L Barnes; B Bresnihan; O Fitzgerald
Journal:  Arthritis Rheum       Date:  1993-07

9.  Immunological abnormalities in psoriatic arthropathy.

Authors:  J Sany; J Clot
Journal:  J Rheumatol       Date:  1980 Jul-Aug       Impact factor: 4.666

10.  Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

Authors:  A B Gottlieb; B Lifshitz; S M Fu; L Staiano-Coico; C Y Wang; D M Carter
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  10 in total

1.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

2.  Ectopic lymphoid neogenesis in psoriatic arthritis.

Authors:  Juan D Cañete; Begoña Santiago; Tineke Cantaert; Raimon Sanmartí; Antonio Palacin; Raquel Celis; Eduard Graell; Beatriz Gil-Torregrosa; Dominique Baeten; José L Pablos
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

3.  CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis.

Authors:  A Koreck; A Surányi; B J Szöny; A Farkas; Z Bata-Csörgö; L Kemény; A Dobozy
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  Periodontal disease in patients with psoriatic arthritis.

Authors:  Kemal Üstün; Ufuk Sezer; Bünyamin Kısacık; Süleyman Ziya Şenyurt; Eda Çetin Özdemir; Gezmiş Kimyon; Yavuz Pehlivan; Kamile Erciyas; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 5.  Immunopathology of psoriasis and psoriatic arthritis.

Authors:  D J Veale; C Ritchlin; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 6.  Traditional and newer therapeutic options for psoriatic arthritis: an evidence-based review.

Authors:  Dafna D Gladman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.

Authors:  Cord H Sunderkötter; Jane Tomimori-Yamashita; Verena Nix; Solange M Maeda; Anca Sindrilaru; Mario Mariano; Clemens Sorg; Johannes Roth
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

8.  Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatment.

Authors:  Sarah Cassell; Arthur Kavanaugh
Journal:  J Immune Based Ther Vaccines       Date:  2005-09-02

9.  Long-term remission and biologic persistence rates: 12-year real-world data.

Authors:  Kieran Murray; Matthew Turk; Yousef Alammari; Francis Young; Phil Gallagher; Tajvur Saber; Ursula Fearon; Douglas J Veale
Journal:  Arthritis Res Ther       Date:  2021-01-13       Impact factor: 5.156

10.  Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis.

Authors:  Lorenz Thurner; Marina Zaks; Klaus-Dieter Preuss; Natalie Fadle; Evi Regitz; Mei Fang Ong; Michael Pfreundschuh; Gunter Assmann
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.